259 related articles for article (PubMed ID: 22001151)
1. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
[TBL] [Abstract][Full Text] [Related]
5. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
[TBL] [Abstract][Full Text] [Related]
6. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
Kiliç A; Gürler B
Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
[TBL] [Abstract][Full Text] [Related]
7. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
Gupta V; Sahu PK
Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
[TBL] [Abstract][Full Text] [Related]
9. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
Sharma A; Gupta R; Ram J; Gupta A
Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
[TBL] [Abstract][Full Text] [Related]
10. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
11. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
Keklikci U; Dursun B; Cingu AK
Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
[TBL] [Abstract][Full Text] [Related]
12. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
[TBL] [Abstract][Full Text] [Related]
13. Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care.
De Smedt SK; Nkurikiye J; Fonteyne YS; Tuft SJ; Gilbert CE; Kestelyn P
Ophthalmology; 2012 Sep; 119(9):1766-72. PubMed ID: 22683059
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.
Daniell M; Constantinou M; Vu HT; Taylor HR
Br J Ophthalmol; 2006 Apr; 90(4):461-4. PubMed ID: 16547328
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
16. Tailored approach to the treatment of vernal keratoconjunctivitis.
Sacchetti M; Lambiase A; Mantelli F; Deligianni V; Leonardi A; Bonini S
Ophthalmology; 2010 Jul; 117(7):1294-9. PubMed ID: 20382430
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients].
Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L
Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374
[TBL] [Abstract][Full Text] [Related]
18. Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis.
Bremond-Gignac D; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Leonardi A;
Am J Ophthalmol; 2020 Apr; 212():116-126. PubMed ID: 31770513
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
